Vioxx: The Downfall of a Drug

Vioxx: The Downfall of a Drug Merck removed one of the world's best-selling painkillers from the market in 2004 after a study showed Vioxx caused an increased risk of serious cardiovascular events, such as stroke and heart attack. Now, Merck agrees to pay $4.85B to end thousands of lawsuits.

Merck Tries to Move Beyond Vioxx Debacle

Medical Journal Publishes Correction on Vioxx Study

Medical Journal Issues Vioxx Study Correction

Conflicted Safety Panel Let Vioxx Study Continue

Data: Vioxx Heart Risks Began Earlier than Thought

Study: Health Risk Remains a Year After Quitting Vioxx

Jury: Vioxx Maker Owes Heart-Attack Victim $9 Million

Merck Ordered to Pay $4.5 Million in N.J. Vioxx Case

Journal Raises New Questions About 2000 Vioxx Study

Jury Clears Vioxx Makers in Death of Florida Man

Houston Vioxx Case Ends in Mistrial

Judge to Set New Trial Date After Vioxx Mistrial

Study Used for Vioxx Defense Questioned

Load more stories

ncG1vNJzZmivp6x7r7zRZ6arn1%2BosrO1xKxmbmhjaH5xgY6voKiwqGLBqbGMnaawppaWua15zp9kmmWUp8Ko